CAMP4 Therapeutics Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.04 | -$2.04 | -$2.04 |
| Q2 2024 | 1 | -$0.92 | -$0.92 | -$0.92 |
| Q3 2024 | 3 | -$1.56 | -$0.45 | -$0.95 |
| Q4 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q1 2025 | 1 | $2.42 | $2.42 | $2.42 |
CAMP4 Therapeutics Corporation Earnings Date And Information
CAMP4 Therapeutics Corporation last posted its earnings results on Monday, July 8th, 2024. The company reported $-1.61 earnings per share for the quarter, missing analysts' consensus estimates of $-0.92 by $0.69. The company had revenue of 53.63 M for the quarter and had revenue of 186.23 M for the year. CAMP4 Therapeutics Corporation has generated $-3 earnings per share over the last year ($-2.52 diluted earnings per share) and currently has a price-to-earnings ratio of -2.43. CAMP4 Therapeutics Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 11th, 2024 based on prior year's report dates.
CAMP4 Therapeutics Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 01/09/2024 | Q3 2024 | -$2.30 | -$2.27 | 0.03 | $56.20 M | $53.63 M |
| 10/10/2023 | Q2 2024 | -$0.11 | $61.71 M | |||
| 07/10/2023 | Q1 2024 | $0.92 | -$0.11 | -1.03 | $70.89 M | |
| 04/27/2023 | Q4 2023 | -$0.22 | $78.51 M | |||
| 12/20/2022 | Q3 2023 | -$0.09 | -$0.13 | -0.04 | $75.29 M | $78.89 M |
| 09/22/2022 | Q2 2023 | -$0.92 | -$0.21 | 0.71 | $72.83 M | |
| 06/23/2022 | Q1 2023 | -$1.15 | -$0.34 | 0.81 | $64.73 M | |
| 04/28/2022 | Q4 2022 | -$1.38 | -$0.26 | 1.12 | $68.38 M | |
| 12/21/2021 | Q3 2022 | -$0.23 | -$0.32 | -0.09 | $77.56 M | $68.78 M |
| 09/23/2021 | Q2 2022 | -$0.15 | $79.01 M | |||
| 06/24/2021 | Q1 2022 | -$0.06 | $79.67 M | |||
| 04/22/2021 | Q4 2021 | $1.15 | -$0.25 | -1.4 | $81.95 M | |
| 12/17/2020 | Q3 2021 | $0.69 | -$0.68 | -1.37 | $82.98 M | $88.01 M |
| 09/24/2020 | Q2 2021 | -$0.46 | -$0.28 | 0.18 | $83.54 M | |
| 06/25/2020 | Q1 2021 | -$0.69 | -$0.42 | 0.27 | $80.22 M | |
| 05/05/2020 | Q4 2020 | -$1.65 | $87.20 M | |||
| 12/19/2019 | Q3 2020 | $3.45 | -$0.22 | -3.67 | $95.11 M | $96.60 M |
| 09/26/2019 | Q2 2020 | $2.53 | -$0.22 | -2.75 | $93.24 M | |
| 06/27/2019 | Q1 2020 | -$0.26 | $89.07 M | |||
| 04/30/2019 | Q4 2019 | $0.33 | $84.38 M |
CAMP4 Therapeutics Corporation Earnings: Frequently Asked Questions
-
When is CAMP4 Therapeutics Corporation's earnings date?
CAMP4 Therapeutics Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 11th, 2024 based off last year's report dates.
-
How can I listen to CAMP4 Therapeutics Corporation's earnings conference call?
The conference call for CAMP4 Therapeutics Corporation's latest earnings report can be listened to online.
-
How can I read CAMP4 Therapeutics Corporation's conference call transcript?
The conference call transcript for CAMP4 Therapeutics Corporation's latest earnings report can be read online.
-
How much revenue does CAMP4 Therapeutics Corporation generate each year?
CAMP4 Therapeutics Corporation (:CAMP) has a recorded annual revenue of $186.23 M.
-
How much profit does CAMP4 Therapeutics Corporation generate each year?
CAMP4 Therapeutics Corporation (:CAMP) has a recorded net income of $186.23 M. CAMP4 Therapeutics Corporation has generated $-2.52 earnings per share over the last four quarters.
-
What is CAMP4 Therapeutics Corporation's price-to-earnings ratio?
CAMP4 Therapeutics Corporation (:CAMP) has a price-to-earnings ratio of -2.43 and price/earnings-to-growth ratio is 0.01.
